Three years of European Parliament’s Environment Committee challenges to EU secondary legislation

Interest in EU secondary legislation has never been higher.

The Environment Committee has a long track record of scrutinising EU secondary legislation. They have long been the most active.

This is important. Most EU legislation – around 97% – is a mix of implementing acts, delegated acts, and still RPS measures.

 

A high threshold to challenge

It is hard to challenge secondary legislation. There are many reasons for this. The threshold to block a delegated act or RPS measure in the EP is 353 votes.

The Council seems less interested in scrutinising secondary legislation from the Commission.  For the delegated legislation, the Council needs a super-qualified majority – 20 Member States, representing 65% of the EU population – and for a RPS Measures QMV (15 Member States representing 65% of the EU population).

These are hard hurdles to get over. Rightfully so. If the EP, or Council, get enough votes against a Commission’s delegated act or RPS measure, the Commission can not adopt it.

What happens if a challenge is successful

For a blocked RPS measure, the Commission can (1) only submit a new draft proposal to the Regulatory Committee, or (2) submit a new ordinary legislative proposal, or (3) take no further action. There is a trend for the Commission to re-submit a proposal with the offending provision that led to the challenge being removed.  The same goes for a delegated act. The Commission can (1) prepare a new delegated act,  or (2)  submit an ordinary legislative proposal, or (3)take no further action.

You’ll see in many of the challenges that the EP highlights the element of the proposal that they take umbrage with. I recall some cases when the Commission took notice early, amended their proposal, and re-submitted a text that would not meet a challenge.

 

Too much scrutiny?

Some take offence with the Environment Committee exercising their role of scrutiny. I think this is wrong. They do not do it very often. My guestimate is that they only call in less than 2% of secondary legislation that is tabled by the Commission.

Tracking the exact numbers would be easier to do if the EP provided access to their own Comitology Newsletters.

Another concern some have raised to me is that some of the challenges are political. It is naive to think that politicians won’t act in a political way. It amounts to hopes that the laws of nature come to a halt on your file.

It appears that the Council has never challenged an implementing act during scrutiny. This is a not surprising as the proposal is dealt with by a Committee made up of Member State officials.

The Environment Committee challenges implementing acts – mainly around GMOs and pesticides. They are often supported by the whole Parliament. They need a simple majority to get adopted. The Commission has to date, simply ignored the EP.

I don’t think challenges are taken lightly. It’s a lot of diligent work to prepare the written challenge and secure support.From the many challenges I’ve read, a lot of diligence has gone into preparing them.

And, as a general rule, I think that more scrutiny of legislation, whether ordinary or secondary, is a good thing.

 

Some trends

There are no real surprises looking at the challenges.

Most are around GMO agricultural plants and pesticides.

Successful challenges benefit from cross-party support to get through the Environment Committee and the Plenary.

There is often not much time between the file gets voted on by the Environment Committee before it is voted on the plenary.

Looking at the voting coalitions, there are familiar trends. A group of progressive MEPs – S&D, Greens, the Left – support the challenges. The EPP and ECR oppose challenges. Renew is usually split down the middle. IDG’s position varies on the issue.

The cordone santitaire is absolute.

 

Link to challenges

Below is the working file I have tidied up. I’ll look to update it and provide the links to all of the Commission’s replies to the challenges.

The successful challenges are highlighted – yellow for Implementing acts and red for RPS measures and delegated acts

This looks at three years of challenges by the Environment Committee.

When Wote watch comes back online, I’ll look to add their excellent links.

For those – maybe students – who want to do more research, I’ve included links to the objection, the EP procedure file, and the Committee minutes for the votes.

If there are any errors, please let me know.

The European Parliament’s Environment Committee is the most active Committee scrutinising the Commission’s output of secondary legislation.

Since the 9th legislature sat for the first time on 10 July 2019, the Environment Committee has seen 72 challenges tabled.

Updated 8 July 2022

A review of the challenges of the Environment Committee

10 July 2019 –

1.  Objection to the extension of the approval periods of the active substances –flumioxazine and others

Implementing Act

Procedure file: 2019/2825

Rapporteur: Anja Hazekamp (GUE/NGL)

Vote in Committee:   25 September 2019

Vote:  For 47, Against: 22, Abstention 1. Link

Vote in Plenary: 10 October 2019

Vote:  For 402, Against 222, Abstentions 39

Commission’s follow-up: SP(2019)669-2019:2825

2. Objection to the extension of the approval periods of active substances

Implementing Act

Procedure file: 2019/2826

Rapporteur: Anja Hazekamp (GUE/NGL)

Debate in Committee:  25 September 2019

Adopted: For 49, Against 20, Abstention: 1. Link

Vote in Plenary: 10 October 2019

Vote: For 402, Against 222, Abstentions 39

Commission’s follow-up: SP2019:2826

3. Objection to GMO Maize MZHG0JG

Implementing Act

Procedure file: 2019/2830

Co-Rapporteurs: Sirpa Pietikäinen (PPE) Günther Sidl (S&D) Nicolae Ştefănuță (Renew) Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL) Eleonora Evi (NI)

Vote in Committee: 25 September 2019

Vote: For 51, Against 15, Abstentions 5 Link

Vote in Plenary: 10 October 2019

Vote: For 436, Against 208, Abstentions 16

Commission’s follow-up: 2019:2830-3

4. Objection to GMO Soybean

Implementing Act

Procedure  file: 2019/2828

Co-Rapporteurs: Sirpa Pietikäinen (PPE), Günther Sidl (S&D), Nicolae Ştefănuță (Renew), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI)

Vote in Committee: 25 September 2019

Vote: For 50, Against 14, Abstentions 7 Link

Vote in Plenary: 10 October 2019

Vote: For 426, Against 208, Abstentions 20

Commission’s follow-up: 4-2019:2828

5. Objection to GMO Maize

Implementing Act

Procedure file: 2019/2829

Co-Rapporteurs: Sirpa Pietikäinen (PPE), Günther Sidl (S&D), Nicolae Ştefănuță (Renew), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI)

Vote in Committee: 25 September 2019

Vote: For 50, Against 16 Abstentions 4 Link

Vote in Plenary: 10 October 2019

Vote: For 435, Against 207, Abstentions 18

Commission’s follow-up: 5.2019:2829

6. Objection on the assessment of the impact of plant protection products on honeybees

RPS

Procedure file: 2019/2776

Co-Rapporteurs: Eric Andrieu (S&D), Martin Hojsík (Renew), Bas Eickhout (Verts/ALE), Anja Hazekamp (GUE/NGL)

Debate in Committee: 21 October 2019

Vote: For 62, Against 4, Abstentions 7 Link

Vote in Plenary: 23 October 2019

Vote: For 533, Against 67, Abstentions 100

Commission’s follow-up: 2019:2776

1.  Objection to the authorisation for a use of chromium trioxide – Cromomed

Implementing Act

Procedure File: 2019/2844

Co-Rapporteurs: Maria Arena (S&D), Martin Hojsík (Renew), Bas Eickhout (Verts/ALE)

Vote in Committee: 21 October 2019

Vote: For 43, Against 28, Abstentions 1 Link

Vote in Plenary: 24 October 2019

Vote: For 301, Against 295, Abstentions 45

Commission’s follow-up:7.2019:2844

8. Objection  pursuant to authorisation GMO cotton LLCotton25

Implementing Act

Porcedure file: 2019/2856

Co-Rapporteurs: Günther Sidl (S&D), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (EPP)

Vote in Committee: 6 November 2019

Vote: For 46, Against 25, Abstentions: 0  Link

Vote in Plenary: 14 November 2019

Vote: For 448, Against 189, Abstentions 28

Commission’s follow up: 8.2019:2856

9. Objection to GMO soya 89788

Implementing Act

Procedure file: 2019/2857

Co-Rapporteurs: Günther Sidl (S&D), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen

Debate in Committee: 6 November 2019

Vote: For 47, Against 25, Abstention 0  Link

Vote in Plenary: 14 November 2019

Vote: For 448, Against 186, Abstentions 30

Commission’s follow up: 9.2019:2857

10. Objection pursuant to the authorisation of GMO maise MON 89034

Implementing Act

Procedure file: 2019/2859

Co-Rapporteurs: Sirpa Pietikäinen, Günther Sidl (S&D),Nicolae Ştefănuță (Renew) Tilly Metz (Verts/ALE),  Anja Hazekamp (GUE/NGL), Eleonora Evi (NI)

Debate in Committee: 6 November 2019

Vote: For 46, Against 24, Abstention 0  Link

Vote in Plenary: 14 November 2019

Vote: Vote: For 465, Against 169, Abstentions 30

Commission’s follow- up: 10.2019:2859

11. Objection to the authorisation of GMO maise Bt11

Implementing Act

Procedure file: 2019/2860

Co-Rapporteurs: Günther Sidl (S&D), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen

Vote in Committee: 6 November 2019

Vote: For 51, Against 21, Abstention 0  Link

Vote in Plenary: 14 November

Vote: For 467, Against 171, Abstentions 27

Commission’s follow-up: 11.2019:2860

12. Objection to Delegated act on classification, labelling, and packaging of substances and mixtures – titanium dioxide

Delegated Act

Procedure file: 2019/2843

Rapporteur: Anna Zalewska (ECR)

Vote in Committee: 2 December 2019

Vote: For 19, Against 47, Abstentions 4  Link

13. Objection to Imports of Pet Food from Saudi-Arabia

Implementing Act

Procedure file: None listed

Rapporteur: Joëlle Mélin (ID)

Vote in Committee: 2 December 2019

Vote: For 12, Against 58, Abstentions 1  Link

14. Objection to the import of food from Japan

Implementing Act

Procedure file: None listed

Procedure file: 2019/2913

Rapporteurs: Michèle Rivasi (Verts/ALE) Sirpa Pietikäinen

Debate in Committee: 2 December 2019

Vote: For 30, Against 40, Abstentions 1  Link

15. Objection to the extension of the active substances benfluralin and others

Implementing Act

Procedure file: 2019/2925

Rapporteurs: Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI

Vote in Committee: 2 December 2019

Vote: For 44, Against 27, Abstentions 0  Link

Vote in Plenary: 18 December 2019

Vote: For 443, Against 216, Abstentions 33

Commission’s follow-up: benfluralin

16. Objection to REACH Restriction lead in PVC

RPS

Procedure file: 2019/2949

Co- Rapporteurs: Bas Eickhout (Verts/ALE) Maria Arena (S&D) Martin Hojsík (Renew)

Vote in Committee: 21 January 2020

Vote: For 42, Against 22, Abstentions 4  Link

Vote in Plenary: 12 February 2020

Vote: For 394, Against 241, Abstentions 13

Commission’s follow-up: 16

17. Objection to the non-approval of propolis extract

Implementing Act

Procedure file: None listed

Rapporteur: Joëlle Mélin (ID)

Vote in Committee: 3 February 2020

Vote: For 7, Against 59, Abstentions 5  Link

18. Objection to authorising GMO soybean 87708

Implementing Act

Procedure file: 2020/2535

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D)Anja Hazekamp (GUE/NGL), Sirpa Pietikäinen (PPE),Eleonora Evi (NI)

Vote in Committee: 3 February 2020

Vote: For 48, Against 22, Abstentions 0  Link

Vote in Plenary: 13 May 2020

Vote: For 477, Against 181, Abstentions 23

Commission’s follow-up: 18

19. Objection to maximum residue levels for cycloxydim and others

RPS

Procedure file: 2020/2603 none listed

Rapporteur: Michèle Rivasi (Greens/EFA)

Vote in Committee: 21 April 2020

Vote: For 45 Against 32, Abstentions 4  Link

Vote in Plenary: 17 September 2020

Vote: For 372, Against 275, Abstentions 39

Commission’s follow-up: MRLcycloxydim

20. Objection to renewing the approval of the active substance pyriproxyfen

Implementing Act

Procedure file: 2020/2662 none listed

Rapporteur: Joëlle Mélin (ID)

Vote in Committee: 28 May 2020

Vote: For 12, Against 51, Abstentions 11  Link

21. Objection to authorisation  to REACHLaw Ltd for certain uses of chromium trioxide

Implementing Act

Procedure file: 2020/2670

Co-Rapporteurs: Bas Eickhout (Verts/ALE) Maria Arena (S&D) Martin Hojsík (Renew)

Vote in Committee: 8 June 2020

Vote: For 38, Against 35, Abstentions 3  Link

Vote in Plenary: 10 July 2020

Vote: For 325, Against 325, Abstentions 35

22. Objection to the extension of the approval periods of the active substances beflubutamid and others

Implementing Act

Procedure file: 2020/2671

Co-Rapporteurs: Anja Hazekamp (GUE/NGL), Maria Arena (S&D), Tilly Metz (Verts/ALE), Eleonora Evi (NI)

Debate in Committee: 8 June 2020

Vote: For 43, Against 30, Abstentions 3   Link

Vote in Plenary: 10 July 2020

Vote: For 415, Against 252, Abstentions 20

23. Objection for food additives  specifications for titanium dioxide (E 171)

RPS

Procedure file 2020/2670 (in resolution listed as 2020/2713)

Co-Rapporteurs: Michèle Rivasi, Eric Andrieu, Eleonora Evi, Joëlle Mélin, Ljudmila Novak, Mick Wallace

Vote in Committee: 7 September 2020

Vote: For 51, Against 11, Abstentions 16   Link

Vote in Plenary: 7 October 2020

Vote: For 443, Against 118, Abstentions 135

24. Objection to maximum levels of acrylamide in certain foodstuffs for infants and young children

RPS

Procedure file: 2020/2735

Co-Rapporteurs: Jutta Paulus, Christel Schaldemose, Martin Hojsík, Eleonora Evi, Sirpa Pietikäinen, Mick Wallace

Vote in Committee: 28 September 2020

Vote: For 51, Against 11, Abstentions 16  Link

Vote in Plenary: 7 October 2020

Vote: For 439, Against 137, Abstentions 90

25. Objection to Restriction on lead shot

RPS

Procedure file: 2020/2771

Co-Rapporteurs: Alexander Bernhuber, Ondřej Knotek, Andrey Slabakov

Vote in Committee: 29 October 2020

Vote: For 33, Against 42, Abstentions 4  Link

Vote in Plenary: 24 November 2020

Vote: For 292, Against 362, Abstentions 39

26. Objection to GMO soya SYHT0H2

Implementing Act

Procedure file: 2020/2838

Co-Rapporteurs: Tilly Metz, Günther Sidl, Anja Hazekamp, Eleonora Evi, Sirpa Pietikäinen

Vote in Committee: 29 October 2020

Vote: For 51, Against 26, Abstentions 3  Link

Vote in Plenary: 11 November 2020

Vote: For 476, Against 178, Abstentions 25

27. Objection to GMO maise MON 87427

Implementing Act

Procedure file: 2020/2836

Co-Rapporteurs: Tilly Metz, Günther Sidl, Anja Hazekamp, Eleonora Evi, Sirpa Pietikäinen

Debate in Committee: 29 October 2020

Vote: For 52, Against 25, Abstentions 3  Link

Vote in Plenary: 11 November 2020

Vote: For 483, Against 178, Abstentions 25

28. Objection to GMO maise

Implementing Act

Procedure file: 2020/2837

Co-Rapporteurs: Tilly Metz, Günther Sidl, Anja Hazekamp, Eleonora Evi, Sirpa Pietikäinen

Vote in Committee: 29 October 2020

Vote: For 57, Against 21, Abstentions 2  Link

Vote in Plenary: 11 November 2020

Vote: For 526, Against 142, Abstentions 18

29. Objection to approving carbendazim as an active substance in biocidal products

Implementing Act

Procedure file: 2020/2852

Co-Rapporteurs: Maria Arena, Michèle Rivasi, Anja Hazekamp, Eleonora Evi

Vote in Committee: 16 November 2020

Vote: For 48, Against 26, Abstentions 3  Link

Vote in Plenary: 25 November 2020

Vote: For 458, Against 219, Abstentions 19

30. Objection to the extension of the active substances chlorotoluron, and others

Implementing Act

Procedure file: 2020/2853

Co-Rapporteurs: Anja Hazekamp, Maria Arena, Tilly Metz, Eleonora Evi

Vote in Committee: 16 November 2020

Vote: For 45, Against 28, Abstentions 4  Link

Vote in Plenary: 25 November 2020

Vote: For 425, Against 231, Abstentions 40

31. Objection to GMO soy bean MON 87751

Implementing Act

Procedure file: 2020/2891

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Vote in Committee:30 November 2020

Vote: For 50, Against 27, Abstentions 3  Link

Vote in Plenary: 17 December 2020

Vote: For 472, Against 194, Abstentions 30

32. Objection to genetically modified maise 87427 

Implementing Act

Procedure file: 2020/2892

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Vote in Committee:30 November 2020

Vote: For 53, Against 26, Abstentions 1  Link

Vote in Plenary: 17 December 2020

Vote: For 486, Against 186, Abstentions 22

33. Objection to genetically modified maise  MON 89034

Implementing Act

Procedure file: 2020/2895

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Vote in Committee:  30 November 2020

Vote: For 53, Against 26, Abstentions 1  Link

Vote in Plenary:17 December 2020

Vote: For 490, Against 184, Abstentions 22

34. Objection to genetically modified maise MIR604 (renewal)

Implementing Act

Procedure file: 2020/2893

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Vote in Committee: 30 November 2020

Vote: For 53, Against 26, Abstentions 1  Link

Vote in Plenary: 17 December 2020

For: 489, Against 185, Abstentions  22

35. Genetically modified soybean MON 87751 × MON 87701 × MON 87708 × MON 89788

Implementing Act

Procedure file: 2020/2891

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Vote in Committee: 30 November 2020

Vote: For 53, Against 26, Abstentions 1

Vote in Plenary: 17 December 2020

Vote: For 472, Against 194, Abstentions 30

36. Objection to GMO maise 89034

Implementing Act

Procedure file: 2020/2895

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Vote in Committee: 30 November 2020

Vote: For 50, Against 27, Abstentions 3  Link

Vote in Plenary: 17 December 2020

Vote: For 490, Against 184, Abstentions 22

37. Objection to MRLs for aclonifen and others

RPS

Procedure file: 2020/2888 – none listed

Rapporteur: Joëlle Mélin

Debate  in Committee: 10 December 2020

Vote: For 9, Against 57, Abstentions 13  Link

38. Objection to MRLs for carbon tetrachloride

RPS

Procedure file: 2020/2873 – none listed

Rapporteur: Joëlle Mélin

Debate in Committee: 10 December 2020

Vote: For 10, Against 64, Abstentions 5  Link

39. Objection to MRLs for fluxapyroxad

RPS

Procedure file: 2020/2872 – None Listed

Rapporteur: Joëlle Mélin

Vote in Committee: 10 December 2020

Vote: For 9, Against 70, Abstentions 0  Link

40. Objection to Hydroxyanthracene derivatives Objection to non-approval of cayenne extract

Implementing Act

Procedure file: 2021/2516 – none listed

Rapporteur: Joëlle Mélin

Debate in Committee: 26 January 2021

Vote: For 9, Against 70, Abstentions 0  Link

41. Objection to the functioning of the Union Registry under Regulation (EU) 2018/841

Delegated  act

Procedure file: 2020/2861

Rapporteur: Nils Torvalds (Renew)

Vote in Committee:  26 January 2021

Vote: For 16, Against 60, Abstentions 2  Link

42. Objection pursuant to Rule 112(2) and (3) on the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin

Implementing Act

Procedure file: 2021/2552

Co-Rapporteurs: Anja Hazekamp, Maria Arena, Tilly Metz

Vote in Committee: 24 February 2021

Vote: For 49, Against 29, Abstention 1  Link

Vote in Plenary: 10 March 2021

Vote: For for 472, Against 214, Abstentions 9

43. Objection pursuant to Rule 112(2) and (3) on the placing on the market of products containing, consisting of or produced from genetically modified cotton GHB614 × T304-40 × GHB119

Implementing Act

Procedure file: 2021/2553

Co-Rapporteurs: Martin Häusling, Günther Sidl, Anja Hazekamp, Sirpa Pietikäinen

Vote in Committee: 25 February 2021

Votes: For 53, Against 25, Abstention 1  Link

Vote in Plenary: 10 March 2021

Votes: For 491, Against 184, Abstentions 20

44. Objection pursuant to Rule 112(2) and (3) on the placing on the market of products containing, consisting of or produced from genetically modified maise MZIR098 (SYN-ØØØ98-3)

Implementing act

Procedure file: 2021/2554

Rapporteurs:Martin Häusling, Günther Sidl, Anja Hazekamp, Sirpa Pietikäinen

Vote in Committee: 25 February 2021

Vote: For 54, Against 25, Abstention 1  Link

Vote in Plenary: 10 March 2021

Votes: For 495, Against 181, Abstentions 19

45. Objection on the draft Commission regulation amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, acrinathrin, Bacillus pumilus QST 2808, chlorantraniliprole, ethirimol, lufenuron, penthiopyrad, picloram and Pseudomonas sp. strain DSMZ 13134 in or on certain products

RPS Measure

Procedure file: 2021/2590

Co-Rapporteurs: Jutta Paulus, Sirpa Pietikäinen, Christel Schaldemose, Mick Wallace

Vote in Committee: 15 April 2021

Vote: For 48, Against 32. Abstentions 0. link.

Vote in Plenary: 27 April  2021

Votes: For 441, Against 242, Abstentions 15

46. Objection European Parliament resolution on draft Commission regulation amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, acrinathrin, Bacillus pumilus QST 2808, chlorantraniliprole, ethirimol, lufenuron, penthiopyrad, picloram and Pseudomonas sp. strain DSMZ 13134 in or on certain products 

RPS Measure

Procedure file: 2021/2590

Rapporteurs: Michèle Rivasi (Greens)

Vote in Committee: 15 April 2021

Vote: For 40 , Against 37, Abstentions 3. link.

Vote in Plenary: 27 April  2021

Votes: For 366,  Against 305, Abstentions 27

47. Objection to draft Commission Implementing Regulation amending Regulation (EU) No 37-2010 to classify the substance  imidacloprid as regards its maximum residue limit in foodstuffs of animal origin

RPS Measure

Procedure file: 2021/2705

Objectors: Grace O’Sullivan (Greens/EFA)

Vote in Committee: 27 May 2021

Vote:  For 49, Against 27, Abstentions 2 Link

Vote in Plenary: 9 June 2021

Vote: For 441, Against 232, Abstain 18

48. Objection to Commission Implementing Regulation (EU) amending Implementing Regulation(EU) 540-2011as regards the extension of the approval periods of several active substances, including flumioxazine

Implementing act

Procedure file: 2021/2706

Co-Rapporteurs: Anja Hazekamp (TheLeft), Maria Arena (S&D), Tilly Metz (Greens/EFA)

Vote in Committee: 27 May 2021

Vote:  For  49, Against 27, Abstentions 2 Link

Plenary: 9 June 2021

Vote: For 434, Against 230, Abstentions 27

49. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean DAS- 81419-2

Implementing act

Procedure file: 2021/2759

Co-Rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE))

Vote in Committee: 21 June 2021

Vote: For 48, Against 28, Abstentions 3 Link

Vote in Plenary: 6 July 2021

Vote For 470, Against 199, Abstentions 23

50. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean DAS- 81419-2 × DAS–44406–6, pursuant to Regulation (EC) No 1829/2003 of the European

Implementing act

Procedure file: 2021/2760

Co-Rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE)

Implementing act

Procedure file: 2021/2760

Vote: 21 June 2021

Vote: For 49, Against 27, Abstentions 3 Link

Vote in Plenary: 6 July 2021

Vote For 470, Against 199, Abstentions 23

53. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing, consisting of or produced from genetically modified maise 1507 × MIR162 × MON810 × NK603 and genetically modified maise combining two or three of the – 1234186ENv2

Implementing act

Procedure file: 2021/2760

Co-Rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE)

Vote in Committee: 21 June 2021

Vote: For 49, Against 28, Abstentions 2 Link

Vote in Plenary: 6 July 2021

Vote: For 470, Against 200, Abstentions 22

54.  Objection pursuant to Rule 112(2) and (3): renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maise Bt 11 (SYN-BTØ11-1) pursuant to Regulation (EC) No 1829/2003 of the Europ–1234187Bt11

Implementing act

Procedure file: 2021/2765

Co-Rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE)

Vote in Commitee: 21 June 2021

Vote: For 49, Against 28, Abstentions 2 Link

Vote in Plenary: 6 July 2021

Vote: For 470, Against 200, Abstentions 22

55. Commission Regulation amending Annex IV to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards the prohibition to feed non-ruminant farmed animals, other than fur animals, with protein derived from animals

RPS

Co- Rapporteurs: Piernicola Pedicini (Verts/ALE), Anja Hazekamp (The Left))

Implementing act

Procedure file: 2021/2765 – no link

Vote: 21 June 2021

Vote: For 35, Against 39, Abstentions 5 Link

56. Objection on the Commission delegated regulation of 26 May 2021 supplementing Regulation (EU) 2019/6 of the European Parliament and of the Council by establishing the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans

Delegated act

Procedure file: 2021/2718

Rapporteur: Martin Häusling (Verts/ALE)

Vote in Committee: 12 July 2021

Vote: For 38, Against 18, Abstentions 22 (link)

Vote in Plenary: 15 September July 2021

Vote For 204, Against 450, Abstentions 32

57. Objection pursuant to Rule 112(2) and (3) to Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances, including chlorotoluron and difenoconazole

Implementing act

Procedure file: 2021/2869

Co-Rapporteurs: Anja Hazekamp, Maria Arena, Tilly Metz

Vote in Committee:  27 September 2021

Vote: For 47, Against 30, Abstentions 0 (Link)

Vote in Plenary :5 October 2021

Vote: For 407, Against 256, Abstentions 24

58. Commission Delegated Regulation supplementing Regulation (EU) 2020/852 of the European Parliament and of the Council by establishing the technical screening criteria for determining the conditions under which an economic activity qualifies as contributing

Delegated act

Procedure file: 2021/2753

Co-Rapporteurs: Nicola Beer, Jessica Polfjärd, Andreas Glück, Emma Wiesner

Vote in ECON-ENVI Committee: 27 September 2021

Vote: For 34, Against 92, Abstentions 4 (Link)

Vote in Plenary: 5 October 2021

Vote: For 227, Against 428, Abstentions 31

59. Objection pursuant to Rule 112(2) and (3) and (4)(c) of the Rules of Procedure on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for flonicam

Implementing act

Procedure file: 2021/2957 – none listed

Rapporteur: Michèle Rivasi (Greens/EFA)

Vote in Committee: 6 December 2021

Vote: For 16, Against 53, Abstentions 5 (Link)

1. Objection pursuant to Rule 112(2) and (3): Authorising the placing on the market of products containing,consisting of or produced from genetically modified soybean

Implementing act

Procedure file: 2021/2947

Co-Rapporteurs:  Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (EPP)

Vote in Committee: 13 January 2022

Vote: For 45, Against 31, Abstentions 2 (link)

Vote in Plenary: 15 February 2022

Vote: For 475, Against  209,  Abstenstions 15

1.  Objection pursuant to Rule 112(2) and (3) renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified cotton

Co-Rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE)

Implementing act

Procedure file: 2021/3006

Vote in Committee: 13 January 2022

Vote: For 45, Against 31, Abstentions 2 (link)

Vote in Plenary: 15 February 2022

Vote: For 477, Against 207, Abstentions 15

1. COVID-19 mRNA

Implementing act

Procedure file: 2021/3052 – none listed

Rapporteur: Sylvia Limmer (ID)

Vote in Committee: 10 February 2022

Vote: For 9, Against 71, Abstentions 2 (link)

1.  Genetically modified cotton GHB811 (BCS-GH811-4)

Co-Rapporteurs: Martin Häusling (Verts/ALE), Anja Hazekamp (The Left), Sirpa Pie tikäinen (PPE), Günther Sidl (S&D)

Implementing act

Procedure file: 2021/3057

Vote in Committee: 10 February 20022

Vote: For 56, Against 29, Abstentions 2 (link)

Vote in Plenary: 9 March 2022

Vote: For 482, Against 198, Abstentions 14

1. Genetically modified oilseed rape 73496

Co-Rapporteurs: Martin Häusling (Verts/ALE), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE), Günther Sidl (S&D)

Implementing act

Procedure file: 2021/3058

Vote in Committee: 10 February 20022

 Vote: For 56, Against 29, Abstentions 2 (link)

Vote in Plenary 9 March 2022

Vote: For 474, Against 205, Abstentions 15

1. Draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for flutianil in or on certain products

RPS

Procedure file: 2022/2524

Co-Rapporteurs: Jutta Paulus (Verts/ALE), Maria Arena (S&D), Sirpa Pietikäinen (PPE), Mick Wallace (The Left))

Vote in Committee: 15 March 20022

Vote: For 47, Against 38, Abstentions 1 (link)

Vote in Plenary 24 March 2022

Vote: Rejected

1.  Objection to IA authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87769 x MON 89788

Implementing act

Procedure file: 2022/2566

 Co-rapporteurs: Martin Häusling (Greens/EFA), Anja Hazekamp (The Left), Sirpa Pietikäinen (EPP), Günther Sidl (S&D))

Vote in Committee: 31 March 2022

Vote: For 53, Against 31, Abstentions 1 (link)

Vote in Plenary: 6 April 2022

Vote: For 420, Against 189, Abstentions 16

1. Objection pursuant to Rule 112(2) and (3) to the Commission Implementing Decision on the annual renewal of the conditional marketing authorisation for the medicinal product for human use “Veklury – remdesivir”

Implementing act

Procedure: 2022/2661 – none listed

Rapporteur: Michèle Rivasi (Verts/ALE)

Vote in Committee: 14 June 2022

Votes: For 23, Against 56, Abstention 1 (link)

68. Commission implementing decision on the annual renewal of the conditional marketing authorisation for the medicinal product for human use “Veklury – remdesivir”

Implementing act

Procedure file: 2022/2661 – none listed

Rapporteur: Joëlle Mélin (ID)

Date: 14 June 2022

Votes: For 6, Against 70, Abstentions 3 (link)

69. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing,consisting of or produced from genetically modified maise NK603 × T25 × DAS-40278-9 and its sub- combination T25 × DAS-40278-9,

Implementing act

Procedure file: 2022/2713

Co-Rapporteurs:  Martin Häusling (Greens/EFA), Anja Hazekamp (The Left), Sirpa Pietikäinen (EPP), Günther Sidl (S&D)

Vote: 14 June 2022

Vote: For 53, Against 26, In favour 53, Abstention 1 (Link)

Vote in Plenary: 23 June 2022

Vote: For 402, Against 173, Abstentions 18

70. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing, consisting of or produced from genetically modified maise DP4114 × MON 810 × MIR604 × NK603 and genetically modified maise combining two or three of t

Implementing act

Procedure file: 2022/2694

 Co-Rapporteurs: Martin Häusling (Greens/EFA), Anja Hazekamp (The Left), Sirpa Pietikäinen (EPP), Günther Sidl (S&D)

Vote in Committee:  14 June 2022

Vote: For 52, Against 27, Abstention 1(Link)

Vote in Plenary: 23 June 2022

Vote: For 298, Against 173, Abstentions 24

71. Objection pursuant to Rule 112(2) and (3) designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council

Co-rapporteur:  Martin Häusling (Greens/EFA), Tiemo Wölken (S&D), Nicolae Ştefănuță (Renew), Anja Hazekamp (The Left)

Implementing act

Procedure file: 2022/2693

Vote in Committee:  14 June 2022

Vote: For 48, Against 27, Abstentions 6 (Link)

Vote in Plenary: 23 June 2022

Vote: For 269, Against 280, Abstentions 56 (link)

72. Objection to Commission Delegated Regulation amending Delegated Regulation (EU) 2021/2139 as regards economic activities in certain energy sectors and Delegated Regulation (EU) 2021/2178 as regards specific public disclosures for those economic activities

Delegated act

Procedure file: 2022/2594

Co-Rapporteurs: : Othmar Karas, Christophe Hansen, Alexander Bernhuber, Sirpa Pietikäinen, Paul Tang, Simona Bonafè, Martin Hojsík, Linea Søgaard-Lidell, Emma Wiesner, Monica Semedo, Claudia Gamon, Róża Thun und Hohenstein, Bas Eickhout and Michael Bloss (on behalf of the Greens/EFA), Silvia Modig and Dimitrios Papadimoulis (on behalf of the LEFT), Evelyn Regner, Rasmus Andresen, Jutta Paulus, Marie Toussaint, Roman Haider, Mick Wallace, Nikolaj Villumsen, Anja Hazekamp, Cornelia Ernst, Malin Björk, José Gusmão, Marisa Matias, Idoia Villanueva Ruiz, Martin Schirdewan, Chris MacManus, Manon Aubry, Manuel Bompard, Petros Kokkalis. Joint committee procedure (Rule 58) Committee on Economic and Monetary Affairs and Committee on the Environment, Public Health and Food Safety

Vote in Committee: 14 June 2022

Vote: For 76, Against 62, Abstention 4. (Link)

Vote in Plenary: 6 July 2022

Votes: For 278, Against 328, Abstentions 33